Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -9.30x is 96% above its 5-year average of -242.18x, near the high end of its 5-year range (-14828.09x–-6.87x).
39.75% above its 12-month average of -15.43x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -27.23x.
INTEREST COVERAGE RATIO
-9.30x
INTEREST COVERAGE RATIO AVG TTM
-15.43x
INTEREST COVERAGE RATIO AVG 3Y
-14.72x
INTEREST COVERAGE RATIO AVG 5Y
-242.18x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+39.75%
CURRENT VS 3Y AVG
+36.81%
CURRENT VS 5Y AVG
+96.16%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.42x
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
-71.59%
vs the sector median at left
Femasys Inc.
Market Cap
$6.31M
Interest Coverage Ratio
-9.30x
TTM Avg
-15.43x
3Y Avg
-14.72x
5Y Avg
-242.18x
Market Cap
$6.01M
Interest Coverage Ratio
-438.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.27M
Interest Coverage Ratio
N/A
TTM Avg
1010.31x
3Y Avg
1010.31x
5Y Avg
509.98x
Market Cap
$5.96M
Interest Coverage Ratio
N/A
TTM Avg
2443.20x
3Y Avg
2443.20x
5Y Avg
2443.20x
Market Cap
$5.99M
Interest Coverage Ratio
-1153.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.46M
Interest Coverage Ratio
-545.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.90M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.58M
Interest Coverage Ratio
-82777.81x
TTM Avg
11.97x
3Y Avg
11.97x
5Y Avg
11.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Femasys Inc. (FEMY) | $6.31M | -9.30x | -15.43x | -14.72x | -242.18x |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.01M | -438.08x | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.27M | N/A | 1010.31x | 1010.31x | 509.98x |
| enVVeno Medical Corporation (NVNO)vs › | $5.96M | N/A | 2443.20x | 2443.20x | 2443.20x |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.99M | -1153.85x | N/A | N/A | N/A |
| Lucyd, Inc (LUCY)vs › | $5.86M | N/A | N/A | N/A | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.46M | -545.69x | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.90M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | -82777.81x | 11.97x | 11.97x | 11.97x |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.69M | -310.21x | N/A | N/A | N/A |
Interest Coverage
-9.3x
Debt/Equity
1.19
Current Ratio
2.14
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -27.23x |
| 2026-03-31 | -23.91x |
| 2025-12-31 | -11.33x |
| 2025-09-30 | -6.87x |
| 2025-06-30 | -7.84x |
| 2025-03-31 | -11.89x |
| 2024-12-31 | -10.72x |
| 2024-09-30 | -12.38x |
| 2024-06-30 | -11.54x |
| 2024-03-31 | -9.58x |
| 2023-12-31 | -28.62x |
| 2023-09-30 | -508.06x |
| 2023-06-30 | -14828.09x |
| 2023-03-31 | -1819.18x |
| 2022-12-31 | -780.94x |
| 2022-09-30 | -509.11x |
| 2022-06-30 | -3012.42x |
| 2022-03-31 | -1054.41x |
| 2021-12-31 | -503.79x |
| 2021-09-30 | -319.13x |
| 2021-06-30 | -521.84x |
| 2021-03-31 | -474.67x |
| 2020-12-31 | -481.06x |
| 2020-09-30 | -416.19x |
| 2020-06-30 | -431.54x |
| 2020-03-31 | -1171.59x |
